CFDE Data Portal | Search RN7SL239P

	Label	Description
	RN7SL239P Gene (Entity type)	ENSG00000242999 - RNA, 7SL, cytoplasmic 239, pseudogene
	GSE135514 dasatinib 8 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE118816 Myo1c knockdown podocyte 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193541 nifurtimox A-549 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210476 rutaecarpine macrophage 11 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx BloodVessel 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Colon 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdrenalGland 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE210476 rutaecarpine macrophage 11 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

RN7SL239P

ENSG00000242999 - RNA, 7SL, cytoplasmic 239, pseudogene

GSE135514 dasatinib 8 v 9 human up

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 1 v 4 human dn

A Gene Set from LINCS

GSE118816 Myo1c knockdown podocyte 0 v 3 human up

A Gene Set from LINCS

GSE193541 nifurtimox A-549 0 v 3 human up

A Gene Set from LINCS

GSE210476 rutaecarpine macrophage 11 v 10 human dn

A Gene Set from LINCS

GTEx BloodVessel 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx Colon 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx AdrenalGland 20-29 vs 30-39 Down

A Gene Set from GTEx

GSE210476 rutaecarpine macrophage 11 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.